Hybrid FMT-MRI applied to in vivo atherosclerosis imaging
about
Advances in optical imaging for pharmacological studies.Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.Shape-parameterized diffuse optical tomography holds promise for sensitivity enhancement of fluorescence molecular tomographyRegion-based diffuse optical tomography with registered atlas: in vivo acquisition of mouse optical properties.PET Molecular Targets and Near-Infrared Fluorescence Imaging of Atherosclerosis.Bioluminescence tomography with structural information estimated via statistical mouse atlas registration
P2860
Hybrid FMT-MRI applied to in vivo atherosclerosis imaging
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Hybrid FMT-MRI applied to in vivo atherosclerosis imaging
@en
Hybrid FMT-MRI applied to in vivo atherosclerosis imaging.
@nl
type
label
Hybrid FMT-MRI applied to in vivo atherosclerosis imaging
@en
Hybrid FMT-MRI applied to in vivo atherosclerosis imaging.
@nl
prefLabel
Hybrid FMT-MRI applied to in vivo atherosclerosis imaging
@en
Hybrid FMT-MRI applied to in vivo atherosclerosis imaging.
@nl
P2093
P2860
P356
P1476
Hybrid FMT-MRI applied to in vivo atherosclerosis imaging
@en
P2093
Baoqiang Li
Foued Maafi
Frederic Lesage
Jean-Claude Tardif
Philippe Pouliot
Romain Berti
P2860
P304
P356
10.1364/BOE.5.001664
P50
P577
2014-04-28T00:00:00Z